Loading
1H
1Life Healthcare Inc Stock: price and insider trades · United States
1Life Healthcare Inc: what insiders have been doing
Every trade that managers of 1Life Healthcare Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector. The past year has been quiet: not a single insider filing for 1Life Healthcare Inc. The previous disclosure was published on 24 February 2023.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
90
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€11M
23 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$900.2M
Net income-US$342.5M-38.1% margin
Last declaration on 24 February 2023
Declarations90 total
21,532 shares@ US$18.0012.0% of flowCommon StockSEC:0001562180-23-001867:0
10,285 shares@ US$18.0016.5% of flowCommon StockSEC:0001562180-23-001849:0
88,385 shares@ US$18.0091.3% of flowCommon StockSEC:0001562180-23-001865:0
99,748 shares@ US$18.0012.6% of flowCommon StockSEC:0001562180-23-001866:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001850:0
7,753 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001851:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001848:0
8,866 shares@ US$18.0095.8% of flowCommon StockSEC:0001562180-23-001863:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001846:0
23,620 shares@ US$18.005.7% of flowCommon StockSEC:0001562180-23-001864:0
12,586 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001847:0
12,586 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001845:0
47,298 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001852:0
11,525 sharesCommon StockSEC:0001562180-23-001539:0
11,525 sharesCommon StockSEC:0001562180-23-001538:0
13,829 sharesCommon StockSEC:0001562180-23-001540:0
4,303 sharesCommon StockSEC:0001562180-23-001537:0
1,051 shares0Common StockSEC:0001562180-23-000488:0
1,051 shares0Common StockSEC:0001562180-23-000496:0
751 shares0Common StockSEC:0001562180-23-000491:0
751 shares0Common StockSEC:0001562180-23-000489:0
751 shares0Common StockSEC:0001562180-23-000490:0
6,116 shares@ US$16.71643.2% of flowCommon StockSEC:0001562180-22-008412:0
200 shares@ US$17.000.1% of flowCommon StockSEC:0001562180-22-008092:0
2,500 shares@ US$11.471.7% of flowCommon StockSEC:0001562180-22-007876:0
25 of 90 declarations
About 1Life Healthcare Inc
1Life Healthcare Inc. (ticker ONEM) was a United States-listed healthcare company, historically traded on the NASDAQ market, and best known under the One Medical brand. Founded in 2007 and headquartered in San Francisco, California, United States, the company built a modern primary-care platform designed to make access to care simpler through a blend of in-person visits, virtual care, and digital tools. Before its acquisition, 1Life Healthcare was not an insurer or drug maker; it was a membership-based healthcare services business focused on the patient relationship and on delivering a more convenient care experience.
Operationally, One Medical’s core business centered on primary care for both consumers and employer-sponsored members. Its service set included online scheduling, prescription renewals, access to medical records, 24/7 virtual visits, routine checkups, preventive care, chronic condition management, and selected mental-health support services. The company’s competitive edge came from its technology-enabled model, consumer-friendly workflow, and office-based footprint in multiple major U.S. urban markets. In a fragmented U.S. primary-care landscape, One Medical positioned itself as a premium, membership-oriented alternative to traditional practices.
Read moreShow less
The most important recent milestone in the company’s history was Amazon’s acquisition. The deal was announced in July 2022 and completed on February 22, 2023. From that point onward, One Medical became part of Amazon’s healthcare strategy rather than an independent public equity story. For investors, that transition matters: the equity thesis for ONEM shifted from standalone operating performance to strategic integration, brand value, and potential ecosystem synergies within Amazon Health Services. Amazon has emphasized the combination of One Medical’s in-office care, digital capabilities, and virtual-care services, and later expanded the proposition to U.S. Prime members through a broader health-care benefit.
For French, Belgian, and Swiss investors, ONEM is best understood as a U.S. healthcare-platform asset that contributed a differentiated primary-care model to a much larger technology and retail ecosystem. Its appeal was driven by recurring membership economics, a strong consumer brand, and a network of care locations across the United States. The key recent developments are therefore the 2023 closing of the Amazon transaction, the subsequent integration into Amazon’s healthcare offering, and the continued use of the One Medical brand as a strategic customer-facing health platform in the United States.
